Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Austin N Kirschner
Affiliation
Vanderbilt University Medical Center
ORCID
Career Start Year
2000
Papers
39
H Index
13
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36961272
Intravesical oncolytic virotherapy and immunotherapy for non-muscle-invasive bladder cancer mouse model.
BJU Int
2023
37276079
Triggering daily online adaptive radiotherapy in the pelvis: Dosimetric effects and procedural implications of trigger parameter-value selection.
J Appl Clin Med Phys
2023
34454047
Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery.
Int J Radiat Oncol Biol Phys
2022
35504501
The Use of Low-Dose Radiation Therapy in Osteoarthritis: A Review.
Int J Radiat Oncol Biol Phys
2022
36413679
Evaluation of 5 Fraction Stereotactic Body Radiation Therapy (SBRT) for Osseous Renal Cell Carcinoma Metastases.
Am J Clin Oncol
2022
36148374
Radiopharmaceuticals as Novel Immune System Tracers.
Adv Radiat Oncol
2022
36209946
Towards differentiation of brain tumor from radiation necrosis using multi-parametric MRI: Preliminary results at 4.7Â T using rodent models.
Magn Reson Imaging
2022
36237749
Radiation Fibrosis After Stereotactic Body Radiation Therapy for Osseous Metastases: A Case Report.
Cureus
2022
36060637
Rodent Model of Brain Radionecrosis Using Clinical LINAC-Based Stereotactic Radiosurgery.
Adv Radiat Oncol
2022
36216733
Academic patterns of practice regarding CT simulation scans and radiology review.
J Med Imaging Radiat Sci
2022
35877201
Selective Cell Size MRI Differentiates Brain Tumors from Radiation Necrosis.
Cancer Res
2022
33356477
Intravesical Anti-PD-1 Immune Checkpoint Inhibition Treats Urothelial Bladder Cancer in a Mouse Model.
J Urol
2021
33706289
Monte Carlo study on dose distributions from total skin electron irradiation therapy (TSET).
Phys Med Biol
2021
34934855
Patient Reported Quality of Life Outcomes After Definitive Radiation Therapy With Absorbable Spacer Hydrogel for Prostate Cancer.
Adv Radiat Oncol
2021
34715657
Targeting for stereotactic radiosurgical thalamotomy based on tremor treatment response.
J Neurosurg
2021
33333150
Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique.
J Am Acad Dermatol
2021
32006066
An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report.
Strahlenther Onkol
2020
30529515
Linear Accelerator-Based Stereotactic Radiosurgery for Cranial Intraparenchymal Metastasis of a Malignant Peripheral Nerve Sheath Tumor: Case Report and Review of the Literature.
World Neurosurg
2019
33343830
Intensity-Modulated Radiotherapy is Superior to Three-Dimensional Conformal Radiotherapy in the Trimodality Management of Muscle-Invasive Bladder Cancer with Daily Cone Beam Computed Tomography Optimization.
J Radiat Oncol
2019
31412954
Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer.
J Immunother Cancer
2019
31213358
Diffuse Primary Cutaneous Anaplastic Large Cell Lymphoma Treated by Rotational Total Skin Electron Beam Radiotherapy with Custom Shielding: Case Report.
J Med Imaging Radiat Sci
2019
30933998
Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway.
PLoS One
2019
30622928
Radiation-associated epithelial-myoepithelial carcinoma among five secondary malignancies: A case report and review of literature.
World J Clin Oncol
2018
27720703
Margin of error for a frameless image guided radiosurgery system: Direct confirmation based on posttreatment MRI scans.
Pract Radiat Oncol
2017
28438420
Scalp-sparing total skin electron therapy in mycosis fungoides: Case report featuring a technique without lead.
Pract Radiat Oncol
2017
28220447
Current Management of Refractory Germ Cell Tumors and Future Directions.
Curr Oncol Rep
2017
26944270
Radiotherapy-induced hemichorea.
Neurology
2016
24790620
Multisector dosimetry in the immediate post-implant period: significant under dosage of the prostate base.
J Contemp Brachytherapy
2014
25505253
PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.
J Natl Cancer Inst
2014
23945202
Treatment approach and outcomes of vaginal melanoma.
Int J Gynecol Cancer
2013
21926898
Trends in the use of postoperative radiation therapy in patients with localized resectable pancreatic cancer.
Am J Clin Oncol
2012
21311176
Eosinophilic pleural effusion complicating allergic bronchopulmonary aspergillosis.
Respiration
2011
20162447
Characteristics of Epstein-Barr virus envelope protein gp42.
Virus Genes
2010
21149717
Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex.
Proc Natl Acad Sci U S A
2010
20668073
Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assays.
J Virol
2010
19217393
Structure of Epstein-Barr virus glycoprotein 42 suggests a mechanism for triggering receptor-activated virus entry.
Structure
2009
17581996
Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion.
J Virol
2007
16973550
Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion.
J Virol
2006
11035793
X-ray crystal structure of an anti-Buckminsterfullerene antibody fab fragment: biomolecular recognition of C(60).
Proc Natl Acad Sci U S A
2000
1 - 39 of 39
Column Actions
Search
Recommended Authors
Soumyajit Roy
Rush University Medical Center
Career Start Year
2013
Number of shared co-authors
0
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year
2012
Number of shared co-authors
0
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year
2011
Number of shared co-authors
0
Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Ting Martin Ma
University of Washington
Career Start Year
2010
Number of shared co-authors
0
Bradley J Stish
Mayo Clinic
Career Start Year
2007
Number of shared co-authors
0
Daniel J Ma
Mayo Clinic
Career Start Year
2005
Number of shared co-authors
0
Eyad Abu-Isa
Ascension Providence Hospital
Career Start Year
2005
Number of shared co-authors
0
Daniel S Higginson
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Albert J Chang
University of California Los Angeles
Career Start Year
2003
Number of shared co-authors
0
Luke Pater
University of Cincinnati
Career Start Year
2002
Number of shared co-authors
1
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2002
Number of shared co-authors
0
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year
2001
Number of shared co-authors
0
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
0
Chandana A Reddy
Cleveland Clinic
Career Start Year
2000
Number of shared co-authors
0
Michelle Alonso-Basanta
Perelman School of Medicine, University of Pennsylvania
Career Start Year
2000
Number of shared co-authors
0
Steve E Braunstein
University of California san francisco
Career Start Year
1998
Number of shared co-authors
0
Sean M McBride
Memorial Sloan Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Helen A Shih
Massachusetts General Hospital and Harvard Medical School
Career Start Year
1997
Number of shared co-authors
0
Phuoc T Tran
University of Maryland School of Medicine
Career Start Year
1996
Number of shared co-authors
0
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year
1994
Number of shared co-authors
0
Kevin Camphausen
National Cancer Institute
Career Start Year
1994
Number of shared co-authors
0
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year
1991
Number of shared co-authors
1
Jeff M Michalski
Washington University School of Medicine
Career Start Year
1990
Number of shared co-authors
0
Charles R Thomas
Oregon Health & Science University
Career Start Year
1990
Number of shared co-authors
0
Ivy A Petersen
Mayo Clinic
Career Start Year
1989
Number of shared co-authors
0
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Career Start Year
1987
Number of shared co-authors
0
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year
1985
Number of shared co-authors
0
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year
1982
Number of shared co-authors
0
John P Kirkpatrick
Duke University Medical Center
Career Start Year
1978
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Guozhen Luo
Vanderbilt University Medical Center
Co-authored papers
9
Alexander D Sherry
University of Texas MD Anderson Cancer Center
Co-authored papers
5
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers
5
Mohamed H Khattab
Vanderbilt University Medical Center
Co-authored papers
4
Joseph S Neimat
University of Louisville
Co-authored papers
3
Fenna T Phibbs
Vanderbilt University Medical Center
Co-authored papers
3
Peter Hedera
University of Louisville
Co-authored papers
2
Hong Yu
Vanderbilt University Medical Center
Co-authored papers
2
Christopher J Lindsell
Duke University
Co-authored papers
1
Bradford C Braden
Co-authored papers
1
Li Wang
Vanderbilt University Medical Center
Co-authored papers
1
Lola B Chambless
Vanderbilt University School of Medicine
Co-authored papers
1
1 - 12